Copyright Reports & Markets. All rights reserved.

Global Erythropoietin (EPO) Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Erythropoietin (EPO) Treatment Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Compression Moulding
    • 1.3.3 Ram Extrusion
    • 1.3.4 Gel Spinning
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Erythropoietin (EPO) Treatment Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Human Body Bulletproof
    • 1.4.3 Automotive Bulletproof
  • 1.5 Global Erythropoietin (EPO) Treatment Market Size & Forecast
    • 1.5.1 Global Erythropoietin (EPO) Treatment Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Erythropoietin (EPO) Treatment Sales Quantity (2019-2030)
    • 1.5.3 Global Erythropoietin (EPO) Treatment Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 DSM
    • 2.1.1 DSM Details
    • 2.1.2 DSM Major Business
    • 2.1.3 DSM Erythropoietin (EPO) Treatment Product and Services
    • 2.1.4 DSM Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 DSM Recent Developments/Updates
  • 2.2 Honeywell
    • 2.2.1 Honeywell Details
    • 2.2.2 Honeywell Major Business
    • 2.2.3 Honeywell Erythropoietin (EPO) Treatment Product and Services
    • 2.2.4 Honeywell Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Honeywell Recent Developments/Updates
  • 2.3 Xingi Technology
    • 2.3.1 Xingi Technology Details
    • 2.3.2 Xingi Technology Major Business
    • 2.3.3 Xingi Technology Erythropoietin (EPO) Treatment Product and Services
    • 2.3.4 Xingi Technology Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Xingi Technology Recent Developments/Updates
  • 2.4 Hunan Zhongtai
    • 2.4.1 Hunan Zhongtai Details
    • 2.4.2 Hunan Zhongtai Major Business
    • 2.4.3 Hunan Zhongtai Erythropoietin (EPO) Treatment Product and Services
    • 2.4.4 Hunan Zhongtai Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Hunan Zhongtai Recent Developments/Updates
  • 2.5 Jonnyma New Material
    • 2.5.1 Jonnyma New Material Details
    • 2.5.2 Jonnyma New Material Major Business
    • 2.5.3 Jonnyma New Material Erythropoietin (EPO) Treatment Product and Services
    • 2.5.4 Jonnyma New Material Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Jonnyma New Material Recent Developments/Updates
  • 2.6 Qianxi Longxian Special Fiber
    • 2.6.1 Qianxi Longxian Special Fiber Details
    • 2.6.2 Qianxi Longxian Special Fiber Major Business
    • 2.6.3 Qianxi Longxian Special Fiber Erythropoietin (EPO) Treatment Product and Services
    • 2.6.4 Qianxi Longxian Special Fiber Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Qianxi Longxian Special Fiber Recent Developments/Updates
  • 2.7 ChangQingTeng High Performance Fiber Material
    • 2.7.1 ChangQingTeng High Performance Fiber Material Details
    • 2.7.2 ChangQingTeng High Performance Fiber Material Major Business
    • 2.7.3 ChangQingTeng High Performance Fiber Material Erythropoietin (EPO) Treatment Product and Services
    • 2.7.4 ChangQingTeng High Performance Fiber Material Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 ChangQingTeng High Performance Fiber Material Recent Developments/Updates
  • 2.8 Shanghai Synertex Material Technology Co., Ltd.
    • 2.8.1 Shanghai Synertex Material Technology Co., Ltd. Details
    • 2.8.2 Shanghai Synertex Material Technology Co., Ltd. Major Business
    • 2.8.3 Shanghai Synertex Material Technology Co., Ltd. Erythropoietin (EPO) Treatment Product and Services
    • 2.8.4 Shanghai Synertex Material Technology Co., Ltd. Erythropoietin (EPO) Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Shanghai Synertex Material Technology Co., Ltd. Recent Developments/Updates

3 Competitive Environment: Erythropoietin (EPO) Treatment by Manufacturer

  • 3.1 Global Erythropoietin (EPO) Treatment Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Erythropoietin (EPO) Treatment Revenue by Manufacturer (2019-2024)
  • 3.3 Global Erythropoietin (EPO) Treatment Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Erythropoietin (EPO) Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Erythropoietin (EPO) Treatment Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Erythropoietin (EPO) Treatment Manufacturer Market Share in 2023
  • 3.5 Erythropoietin (EPO) Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Erythropoietin (EPO) Treatment Market: Region Footprint
    • 3.5.2 Erythropoietin (EPO) Treatment Market: Company Product Type Footprint
    • 3.5.3 Erythropoietin (EPO) Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Erythropoietin (EPO) Treatment Market Size by Region
    • 4.1.1 Global Erythropoietin (EPO) Treatment Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Erythropoietin (EPO) Treatment Consumption Value by Region (2019-2030)
    • 4.1.3 Global Erythropoietin (EPO) Treatment Average Price by Region (2019-2030)
  • 4.2 North America Erythropoietin (EPO) Treatment Consumption Value (2019-2030)
  • 4.3 Europe Erythropoietin (EPO) Treatment Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Erythropoietin (EPO) Treatment Consumption Value (2019-2030)
  • 4.5 South America Erythropoietin (EPO) Treatment Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Erythropoietin (EPO) Treatment Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Erythropoietin (EPO) Treatment Sales Quantity by Type (2019-2030)
  • 5.2 Global Erythropoietin (EPO) Treatment Consumption Value by Type (2019-2030)
  • 5.3 Global Erythropoietin (EPO) Treatment Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Erythropoietin (EPO) Treatment Sales Quantity by Application (2019-2030)
  • 6.2 Global Erythropoietin (EPO) Treatment Consumption Value by Application (2019-2030)
  • 6.3 Global Erythropoietin (EPO) Treatment Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Erythropoietin (EPO) Treatment Sales Quantity by Type (2019-2030)
  • 7.2 North America Erythropoietin (EPO) Treatment Sales Quantity by Application (2019-2030)
  • 7.3 North America Erythropoietin (EPO) Treatment Market Size by Country
    • 7.3.1 North America Erythropoietin (EPO) Treatment Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Erythropoietin (EPO) Treatment Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Erythropoietin (EPO) Treatment Sales Quantity by Type (2019-2030)
  • 8.2 Europe Erythropoietin (EPO) Treatment Sales Quantity by Application (2019-2030)
  • 8.3 Europe Erythropoietin (EPO) Treatment Market Size by Country
    • 8.3.1 Europe Erythropoietin (EPO) Treatment Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Erythropoietin (EPO) Treatment Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Erythropoietin (EPO) Treatment Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Erythropoietin (EPO) Treatment Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Erythropoietin (EPO) Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Erythropoietin (EPO) Treatment Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Erythropoietin (EPO) Treatment Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Erythropoietin (EPO) Treatment Sales Quantity by Type (2019-2030)
  • 10.2 South America Erythropoietin (EPO) Treatment Sales Quantity by Application (2019-2030)
  • 10.3 South America Erythropoietin (EPO) Treatment Market Size by Country
    • 10.3.1 South America Erythropoietin (EPO) Treatment Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Erythropoietin (EPO) Treatment Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Erythropoietin (EPO) Treatment Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Erythropoietin (EPO) Treatment Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Erythropoietin (EPO) Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Erythropoietin (EPO) Treatment Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Erythropoietin (EPO) Treatment Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Erythropoietin (EPO) Treatment Market Drivers
  • 12.2 Erythropoietin (EPO) Treatment Market Restraints
  • 12.3 Erythropoietin (EPO) Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Erythropoietin (EPO) Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Erythropoietin (EPO) Treatment
  • 13.3 Erythropoietin (EPO) Treatment Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Erythropoietin (EPO) Treatment Typical Distributors
  • 14.3 Erythropoietin (EPO) Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Erythropoietin (EPO)/hematopoietin is a glycoprotein hormone that triggers production of red blood cells in the bone marrow through erythropoiesis. Erythropoietin drug was developed with the objective to treat anemic conditions caused from end stage renal disease (ESRD) disease treatments and dialysis procedures. Followed by ESRD anemic condition, EPO drugs have gained approvals for chemotherapy-induced anemia. After post-abbreviated new drug application (ANDA) approvals and high success rate of EPO applications for chemotherapy-induced anemia, original biopharmaceutical companies turned their attention to another form of induced anemia, namely ART-induced anemia (among HIV patients).

    According to our (Global Info Research) latest study, the global Erythropoietin (EPO) Treatment market size was valued at US$ 10410 million in 2023 and is forecast to a readjusted size of USD 15320 million by 2030 with a CAGR of 5.6% during review period.
    Rise in prevalence of anemic conditions induced from end stage renal disease treatment, chemotherapy, and antiretroviral treatment (ART) is the primary factor that propels growth of the erythropoietin market. Hence, rise in number of treatment cycles for chemotherapy and increase in incidences of end stage renal diseases (dialysis) has increased demand for EPO. Side effects associated with EPO including arterial hypertension, iron deficiency, and influenza-like syndrome and longer duration of EPO treatment (4-6 weeks) restrain growth of the erythropoietin drugs market. In addition, rise in trends of commercialization for erythropoietin biosimilars, readily available reimbursements, favorable government regulations, and increase in level of awareness regarding benefits of EPO therapeutics boost growth of the erythropoietin drugs market.
    This report is a detailed and comprehensive analysis for global Erythropoietin (EPO) Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Erythropoietin (EPO) Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
    Global Erythropoietin (EPO) Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
    Global Erythropoietin (EPO) Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2019-2030
    Global Erythropoietin (EPO) Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Erythropoietin (EPO) Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Erythropoietin (EPO) Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include DSM, Honeywell, Xingi Technology, Hunan Zhongtai, Jonnyma New Material, Qianxi Longxian Special Fiber, ChangQingTeng High Performance Fiber Material, Shanghai Synertex Material Technology Co., Ltd., etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Erythropoietin (EPO) Treatment market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Compression Moulding
    Ram Extrusion
    Gel Spinning
    Others
    Market segment by Application
    Human Body Bulletproof
    Automotive Bulletproof
    Major players covered
    DSM
    Honeywell
    Xingi Technology
    Hunan Zhongtai
    Jonnyma New Material
    Qianxi Longxian Special Fiber
    ChangQingTeng High Performance Fiber Material
    Shanghai Synertex Material Technology Co., Ltd.
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Erythropoietin (EPO) Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Erythropoietin (EPO) Treatment, with price, sales quantity, revenue, and global market share of Erythropoietin (EPO) Treatment from 2019 to 2024.
    Chapter 3, the Erythropoietin (EPO) Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Erythropoietin (EPO) Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Erythropoietin (EPO) Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Erythropoietin (EPO) Treatment.
    Chapter 14 and 15, to describe Erythropoietin (EPO) Treatment sales channel, distributors, customers, research findings and conclusion.

    Buy now